Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · June 04, 2022

Remyelination in Humans Due to a Retinoid-X Receptor Agonist Is Age-Dependent

Annals of Clinical and Translational Neurology

 

Additional Info

Disclosure statements are available on the authors' profiles:

Annals of Clinical and Translational Neurology
Remyelination in humans due to a retinoid-X receptor agonist is age-dependent
Ann Clin Transl Neurol 2022 May 19;[EPub Ahead of Print], CE McMurran, T Mukherjee, JWL Brown, AW Michell, DT Chard, RJM Franklin, AJ Coles, NG Cunniffe

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading